Surgery After Primary Dexamethasone Treatment for Patients with Chronic Subdural Hematoma-A Retrospective Study

Dana C Holl1, Rahman Fakhry2, Clemens M F Dirven2

  • 1Department of Neurosurgery, Erasmus Medical Center, Erasmus MC Stroke Center, Rotterdam, the Netherlands; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands.

World Neurosurgery
|March 11, 2022
PubMed

Insights

Over a third of patients with chronic subdural hematoma (CSDH) treated with dexamethasone required further surgery. Factors like larger hematoma size and specific imaging characteristics predicted the need for surgical intervention in these CSDH cases.

Area of Science:

  • Neurosurgery
  • Neurology
  • Radiology

Background:

  • Chronic subdural hematoma (CSDH) is a significant neurological condition.
  • Dexamethasone is increasingly used as a primary treatment for CSDH.
  • Quantifying the need for subsequent surgery after dexamethasone treatment is crucial for patient management.

Purpose of the Study:

  • To determine the rate of additional surgery required in patients with CSDH primarily treated with dexamethasone.
  • To identify patient-specific characteristics and CSDH features associated with the need for further surgical intervention.

Main Methods:

  • Retrospective analysis of 283 CSDH patients treated with dexamethasone across three hospitals (2008-2018).
  • Primary outcome: need for additional surgery.
  • Statistical analysis included univariable and multivariable logistic regression to identify associated factors.

Main Results:

  • Over one-third (37.8%) of patients required additional surgery.
  • Factors associated with increased odds of surgery included higher Markwalder Grade, statin use, larger midline shift, greater hematoma thickness, bilateral, and separated hematomas.
  • Antithrombotic use and trabecular hematoma characteristics were associated with a lower likelihood of surgery.

Conclusions:

  • A substantial proportion of CSDH patients treated with dexamethasone necessitate additional surgical procedures.
  • Patient characteristics, particularly those indicating more severe disease like larger hematoma dimensions and specific imaging patterns, are linked to the need for surgery.
Abstract

Related Concept Videos